Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Zhubei
Clinical trial register · Taiwan

Clinical Trials in Zhubei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2860 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2860
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 1913 Taichung 998 Kaohsiung City 827 Tainan 734 Taoyuan 567

Trials with a site in Zhubei

12 of 2860 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
AstraZeneca
Phase 3
1,500
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Zhubei
2026-08-20
Recruiting
Janssen Research & Development, LLC
Phase 2
68
Taichung, Tainan, Taipei, Zhubei
2026-07-28
Recruiting
AstraZeneca
Phase 3
900
Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan, Zhubei
2026-07-06
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Tainan, Taipei, Taoyuan, Zhubei
2026-05-22
Recruiting
AstraZeneca
Phase 3
245
Kaohsiung City, New Taipei City, Taichung, Tainan, Tainan County, Taipei, Taoyuan, Zhubei
2026-04-13
Recruiting
Bristol-Myers Squibb
Phase 3
850
Zhubei, New Taipei City, Taichung, Taipei
2026-03-16
Active, closed
AstraZeneca
Phase 3
212
Taichung, Taipei, Taoyuan, Zhubei
2025-08-07
Active, closed
Trust Bio-sonics, Inc.
Phase 3
150
Keelung, Taichung, Taipei, Zhubei
2025-03-18
Recruiting
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
NCT06678724Head and Neck Cancers- Squamous Cell, Head and Neck Cancer Metastatic, Recurrent Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital
Observational
30
Zhubei
2025-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Zhubei, Taipei, Taoyuan
2024-06-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Changhua County, Zhubei, Taichung, Taipei, Taoyuan
2023-10-25
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-taiwan/city/zhubei

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,860 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Zhubei.

How many clinical trials are recruiting in Zhubei?

8 of the 12 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhubei), 12 studies
PhaseStudiesRecruitingShare
Phase 310683.3%
Observational118.3%
Phase 2118.3%

Most active sponsors

Lead sponsors with the most studies (Zhubei)
Lead sponsorStudiesRecruiting
AstraZeneca43
Janssen Research & Development, LLC22
Merck Sharp & Dohme LLC21
Bristol-Myers Squibb11
National Taiwan University Hospital11
Pfizer10
Trust Bio-sonics, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.